Atrasentan in Patients With Proteinuric Glomerular Diseases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005
- Status
- TERMINATED
- Phase
- PHASE2
Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis Participants
- Status
- COMPLETED
- Phase
- PHASE1
MAP to Provide Access to Nilotinib, for Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Study of Efficacy and Safety of Twice Daily Oral LNP023 in Adult PNH Patients With Residual Anemia Despite Anti-C5 Antibody Treatment
- Status
- COMPLETED
- Phase
- PHASE3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Observational Study for Melanoma Adjuvant Treatment With Tafinlar® + Mekinist® (Dabrafenib + Trametinib)
- Status
- COMPLETED
- Phase
- N/A
Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum Malaria
- Status
- COMPLETED
- Phase
- PHASE2
Compassionate Use Program BRAF Mutation-positive Patients in the Adjuvant Treatment of Melanoma After Surgical Resection
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Observational Study to Evaluate Fluid Resolution and Effectiveness in Patients Receiving Beovu in Neovascular Age-related Macular Degeneration and Visual Impairment Due to Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- N/A
Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Managed Access Program (MAP) for Patients Diagnosed With Secondary Progressive Multiple Sclerosis With Active Disease
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear Palsy
- Status
- COMPLETED
- Phase
- PHASE1
177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Nilotinib, for Patients With CML-CP or CML-AP
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Study of Efficacy and Safety of Voretigene Neparvovec in Japanese Patients With Biallelic RPE65 Mutation-associated Retinal Dystrophy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Mechanism of Action of Ligelizumab (QGE031) in Patients With Chronic Urticaria
- Status
- TERMINATED
- Phase
- PHASE1
Managed Access Program Cohort Treatment Plan CTMT212X2002I to Provide Access to Trametinib and Dabrafenib Combination Therapy for Patients With BRAF V600 Mutation-positive Advanced Non-Small Cell Lung Cancer
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A